ebook img

Biochemistry and Molecular Genetics of Cancer Metastasis: Proceedings of the Symposium on Biochemistry and Molecular Genetics of Cancer Metastasis Bethesda, Maryland — March 18–20, 1985 PDF

338 Pages·1986·11.94 MB·English
Save to my drive
Quick download
Download
Most books are stored in the elastic cloud where traffic is expensive. For this reason, we have a limit on daily download.

Preview Biochemistry and Molecular Genetics of Cancer Metastasis: Proceedings of the Symposium on Biochemistry and Molecular Genetics of Cancer Metastasis Bethesda, Maryland — March 18–20, 1985

BIOCHEMISTRY AND MOLECULAR GENETICS OF CANCER METASTASIS DEVELOPMENTS IN ONCOLOGY F.J. Cleton and J.W.I.M. Simons, eds.: Genetic Origins of Tumour Cells. 90-247-2272-l. J. Aisner and P. Chang, eds.: Cancer Treatment and Research. 90-247-2358-2. B.W. Ongerboer de Visser, D.A. Bosch and W.M.H. van Woerkom-Eykenboom, eds.: Neuro- oncology: Clinical and Experimental Aspects. 90-247-2421-X. K. Hellmann, P. Hilgard and S. Eccles, eds.: Metastasis: Clinical and Experimental Aspects. 90-247-2424-4. H.F. Seigler, ed.: Clinical Management of Melanoma. 90-247-2584-4. P. Correa and W. Haenszel, eds.: Epidemiology of Cancer of the Digestive Tract. 90-247-2601-8. L.A. Liotta and I.R. Hart, eds.: Tumour Invasion and Metastasis. 90-247-2611-5. J. Banoczy, ed.: Oral Leukoplakia. 90-247-2655-7. C. Tijssen, M. Halprin and L. Endtz, eds.: Familial Brain Tumours. 90-247-2691-3. F.M. Muggia, C.W. Young and S.K. Carter, eds.: Anthracycline Antibiotics in Cancer. 90-247-2711-1. B.W. Hancock, ed.: Assessment of Tumour Response. 90-247-2712-X. D.E. Peterson, ed.: Oral Complications of Cancer Chemotherapy. 0-89838-563-6. R. Mastrangelo, D.G. Poplack and R. Riccardi, eds . : Central Nervous System Leukemia. Preven- tion and Treatment. 0-89838-570-9. A. Polliack, ed.: Human Leukemias. Cytochemical and Ultrastructural Techniques in Diagnosis and Research. 0-89838-585-7. W. Davis, C. Maitoni and S. Tanneberger, eds.: The Control of Tumor Growth and its Biological Bases. 0-89838-603-9. A.P.M. Heintz, C. Th. Griffiths and 1.B. Trimbos, eds.: Surgery in Gynecological Oncology. 0-89838-604-7. M.P. Hacker, E.B. Double and I. Krakoff, eds.: Platinum Coordination Complexes in Cancer Chemotherapy. 0-89838-619-5. M.J. van Zwieten. The Rat as Animal Model in Breast Cancer Research: A Histopathological Study of Radiation- and Hormone-Induced Rat Mammary Tumors. 0-89838-624-l. B. Lowenberg and A. Hogenbeck, eds.: Minimal Residual Disease in Acute Leukemia. 0-89838-630-6. I. van der Waal and G.B. Snow, eds.: Oral Oncology. 0-89838-631-4. B.W. Hancock and A.M. Ward, eds.: Immunological Aspects of Cancer. 0-89838-664-0. K.V. Honn and B.F. Sloane, eds.: Hemostatic Mechanisms and Metastasis. 0-89838-667-5. K.R. Harrap, W. Davis and A.N. Calvert, eds.: Cancer Chemotherapy and Selective Drug Development. 0-89838-673-X. V.D. Velde, 1.H. Comelis and P.H. Sugarbaker, eds.: Liver Metastasis. 0-89838-648-5. D.l. Ruiter, K. Welvaart and S. Ferrone, eds.: Cutaneous Melanoma and Precursor Lesions. 0-89838-689-6. S.B. Howell, ed.: Intra-Arterial and Intracavitary Cancer Chemotherapy. 0-89838-691-8. D.L. Kisner and J.F. Smyth, eds.: Interferon Alpha-2: Pre-Clinical and Clinical Evaluation. 0-89838-701-9. P. Furmanski, J.C. Hager and M.A. Rich, eds.: RNA Tumor Viruses, Oncogenes, Human Cancer and Aids: On the Frontiers of Understanding. 0-89838-703-5. J.E. Talmadge, I.J. Fidler and R.K. Oldham: Screening for Biological Response Modifiers: Methods and Rationale. 0-89838-712-4. J.C. Bottino, R.W. Opfell and F.M. Muggia, eds.: Liver Cancer. 0-89838-713-2. P.K. Pattengale, R.J. Lukes and C.R. Taylor, eds.: Lymphoproliferative Diseases: Pathogenesis, Diagnosis, Therapy. 0-89838-725-6. F. Cavalli, G. Bonadonna and M. Rozencweig, eds.: Malignant Lymphomas and Hodgkin's Disease. 0-89838-727-2. L. Baker, F. Valeriote and V. Ratanatharathom, eds.: Biology and Therapy of Acute Leukemia. 0-89838-728-0. J. Russo, ed.: Immunocytochemistry in Tumor Diagnosis. 0-89838-737-X. R.L. Ceriani, ed.: Monoclonal Antibodies and Breast Cancer. 0-89838-739-6. D.E. Peterson, G.E. Elias and S.T. Sonis, eds.: Head and Neck Management of the Cancer Patient. 0-89838-747-7. D.M. Green: Diagnosis and management of Malignant Solid Tumors in Infants and Children. 0-89838-750-7. K.A. Foon and A.C. Morgan, Jr., eds.: Monoclonal Antibody Therapy of Human Cancer. 0-89838-754-X. J.O. McVie, et ai, eds., Clinical and Experimental Pathology of Lung Cancer. 0-89838-764-7. K.V. Honn. W.E. Powers and B.F. Sloane, eds.: Mechanisms of Cancer Metastasis. 0-89838-765-5. BIOCHEMISTRY AND MOLECULAR GENETICS OF CANCER METASTASIS Proceedings of the Symposium on Biochemistry and Molecular Genetics of Cancer Metastasis Bethesda, Maryland - March 18-20, 1985 edited by Karoly Lapis Semmelweis Medical University Budapest, Hungary Lance A. Liotta National Institutes of Health Bethesda, Maryland Alan S. Rabson National Institutes of Health Bethesda, Maryland Martinus Nijhoff Publishing a member of the Kluwer Academic Publishers Group Boston I Dordrecht I Lancaster Distributors for North America: Kluwer Academic Publishers 190 Old Derby Street Hingham, Massachusetts 02043, USA Distributors for the UK and Ireland: Kluwer Academic Publishers MTP Press Limited Falcon House, Queen Square Lancaster LAI IRN, UNITED KINGDOM Distributors for all other countries: Kluwer Academic Publishers Group Distribution Centre Post Office Box 322 3300 AH Dordrecht, THE NETHERLANDS Library of Congress Cataloging-in-Publication Data Symposium on Biochemistry and Molecular Genetics of Cancer Metastasis (1985 : Bethesda, Md.) Biochemistry and molecular genetics of cancer metastasis. (Developments in oncology) Includes bibliographies and index. 1. Metastasis-Congresses. 2. Pathology, Molecular- Congresses. 3. Cancer-Genetic aspects-Congresses. 4. Cancer-Immunological aspects-Congresses. 5. Molecular genetics-Congresses. I. Lapis, Karoly. II. Liotta, L. A. (Lance A.) III. Rabson, Alan S., 1926- IV. Title. V. Series. [DNLM: 1. Neoplasm Metastasis-congresses. WI DE998N I QZ 202 S9795b 1985) RC269.S39 1985 616.99 '407 85-30980 ISBN-13: 978-1-4612-9416-0 e-ISBN-13: 978-1-4613-2299-3 DOl: 10.1007/978-1-4613-2299-3 Copyright © 1986 by Martinus Nijhoff Publishing, Boston Softcover reprint of the hardcover 1s t edition 1986 All rights reserved. No part of this publication may be reproduced, stored in a retrieval system, or transmitted in any form or by any means, mechanical, photocopying, recording, or otherwise, without written permission of the publisher, Martinus Nijhoff Publishing, 190 Old Derby Street, Hingham, Massachusetts 02043. CONTENTS CONTRIBUTING AUTHORS viii PREFACE xvii Part One - Biochemistry and Molecular Biology Aspects 1. Biochemical and molecular biology approaches to study cancer 3 metastases L. A. Liotta 2. Use of the chick embryo in studying the molecular genetics 11 of metastasis A. F. Chambers 3. Integral membrane adhesion glycoproteins: What is their fate 25 during metastasis? C. H. Damsky, K. A. Knudsen, A. F. Horwitz, M. J. Wheelock, P. Gruber, and C. A. Buck 4. Peptide fragments of fibronectin and laminin: Role in cell adhesion and inhibition of experimental tumor metastasis 43 L. Furcht, M. Basara, A. Norden-Skubitz, S. Palm, J. McCarthy, and D. Sas 5. Role of ras oncogenes in experimental models of metastasis 55 U. P. Thorgeirsson, T. Turpeenniemi-Hujanen, M. E. Sobel, J. E. Talmadge, and L. A. Liotta 6. Expression of p21ras gene products in fresh primary and meta- static human tumor tissue 65 G. E. Gallick, R. Kurzrock, and J. U. Gutterman 7. A role for differentiation arrest in the development of neural crest tumors 73 L. J. Helman, C. J. Thiele, W. M. Linehan, and M. A. Israel 8. Genetic and epigenetic regulation of the metastatic phenotype: A basis for resolving the controversy regarding its selective or random nature and variable phenotypic stability 83 R. S. Kerbel, P. Frost, and R. G. Liteplo 9. Cytochemical cell typing of metastatic tumors according to their cytoskeletal proteins 101 R. Moll and W. W. Franke 10. Biochemistry and molecular biology RAWII? large cell lymphoma 115 G. L. Nicolson, V. Rotter, D. Wolf, T. Irimura, C. L. Reading, M. Blick, R. La Biche, and M. Frazier vi 11. Karyotypic progression and metastasis formation of human tumors 129 P. C. Nowell and G. Balaban 12. Morphological and functional alterations of occ1udens, ad- herens, and gap junctions in cancer 137 B. U. Pauli and R. S. Weinstein 13. Pattern of basement membrane degradation by metastatic tumor cell enzymes 151 K. Tryggvason Part Two - Immunologic Mechanisms 14. Gene products of the major histocompatibility complex control the metastatic phenotype of tumor cells 167 L. Eisenbach, S. Katzav, G. HMrnrnerling, S. Segal, and M. Feldman 15. Generation of metastatic cells via somatic cell fusion: A possible mechanism for tumor progression in-vivo 185 P. De Baetselier, E. Roos, L. Brys, L. Remel~nd M. Feldman 16. The recognition and destruction of metastatic cells by tumoricidal macrophages 199 I. J. Fidler 17. Biological response modifiers for the therapy of metastases 213 R. B. Herberrnan, R. H. Wiltrout, R. R. Salup, J. R. Ortaldo, and E. Gorelik 18. Differences in cell surface characteristics of poorly and highly metastatic Lewis lung tumor variants 225 K. Lapis, J. Timar, F. Timar, K. Pal, and L. Kopper 19. Characteristics of LL2 and its lectin-resistant not metas- tasizing variants 237 C. Radzikowski, D. Dus, A. Opolski, and L. Strzadala 20. A role for cell surface sialic acid in liberating meta- static tumor cells from host control 251 V. Schirrmacher, J. Dennis, C. A. Waller, and P. Altevogt Part Three - Clinical Perspectives and Applications 21. Tumor heterogeneity and empirical clinical cancer chemotherapy: Current status and future prospects 265 S. K. Carter 22. Hormonal regulation of metastases: Prospects for pharmaco- logical manipulation 279 R. G. Greig 23. Use of anti-tumor MABs for diagnosis and immunotherapy of human tumors 293 H. Koprowski 24. New approaches to the adoptive immunotherapy of established metastatic cancer using lyrnphokine-activated killer cells and recombinant interleukin-2 307 S. A. Rosenberg and J. J. Mule 25. Preclinical screening of biological response modifiers: Application to the treatment of metastatic disease 321 J. E. Talmadge viii CONTRIBUTING AUTHORS Altevogt, Dr. P. Institut fur Immunologie und Genetik Deutsches Krebsforschungszentrum D-6900 Heidelberg Federal Republic of Germany Balaban, Dr. G. Department of Human Genetics University of Pennsylvania School of Medicine Philadelphia, PA 19104 Basara, Dr. M. Department of Laboratory Medicine and Pathology University of Minnesota Minneapolis, MN 55455 Blick, Dr. M. Department of Clinical Immunology and Biological Therapy The University of Texas M.D. Anderson Hospital and Tumor Institute Houston, TX 77030 Brys, Dr. 1. Instituut Voor Moleculaire Biologie Vrije Universiteit Brusse1 B 1640 St.-Genesius-Rode Paardenstraat 65 Brussels, Belgium Buck, Dr. C. A. The Wistar Institute 36th & Spruce Streets Philadelphia, PA 19104 Carter, Dr. S. K. Vice President, Anti-Cancer Research Bristol-Myers Company Pharmaceutical Research and Developmental Division 345 Park Avenue New York, NY 10154 Chambers, Dr. A. F. The London Regional Cancer Centre and Department of Radiation Oncology University of Western Ontario London, Ontario, N6A 4GS, Canada ix Damsky, Dr. C. H. Departments of Oral Biology and Anatomy Schools of Dentistry and Medicine HSW 681 University of California San Francisco, CA 94341 De Baetselier, Dr. P. Instituut Voor Moleculaire Biologie Vrije Universiteit Brussel B 1640 St.-Genesius-Rode Paardenstraat 65 Brussels, Belgium Dennis, Dr. J. Department of Pathology Richardson Laboratory Queen's University Kingston, Canada Dus, Dr. D. Department of Tumor Immunology The Ludwik Hirszfeld Institute of Immunology and Experimental Therapy Polish Academy of Sciences Wroclaw, Poland Eisenbach, Dr. L. Department of Cell Biology The Weizmann Institute of Science Rehovot, Israel Feldman, Dr. M. Department of Cell Biology The Weizmann Institute of Science Rehovot, Israel Fidler, Dr. Isaiah J. Department of Cell Biology University of Texas M.D. Anderson Hospital and Tumor Institute 6723 Bertner Avenue Houston, TX 77030 Franke, Dr. W. W. Institute of Cell and Tumor Biology German Cancer Research Center D-6900 Heidelberg Federal Republic of Germany Frazier, Dr. M. Department of Medicine Baylor College of Medicine Houston, TX 77030 x Frost, Dr. P. Department of Cell Biology University of Texas System Cancer Center M.D. Anderson Hospital and Tumor Institute Houston, TX 77030 Furcht, Dr. L. T. Stone Professor of Pathology Department of Laboratory Medicine and Pathology University of Minnesota Medical School Box 609 Mayo Memorial Building 420 Delaware Street S.E. Minneapolis, MN 55455-0315 Gallick, Dr. G. Department of Tumor Biology University of Texas M.D. Anderson Hospital and Tumor Institute 6723 Bertner Avenue Houston, TX 77030 Gorelik, Dr. E. Biological Therapeutics Branch Biological Response Modifiers Program Division of Cancer Treatment National Cancer Institute Frederick, MD 21701 Greig, Dr. R. Assistant Director Department of Tumor Biology L-I09 Smith Kline & French Laboratories 1500 Spring Garden Street P.O. Box 7929 Philadelphia, PA 19101 Gruber, Dr. P. The Wistar Institute 36th & Spruce Streets Philadelphia, PA 19104 Gutterman, Dr. J. U. Clinical Immunology M.D. Anderson Hospital and Tumor Institute Houston, TX 77030 HHmmerling, Dr. G. Institute for Immunology and Genetics German Cancer Research Center D-6900 Heidelberg Federal Republic of Germany

See more

The list of books you might like

Most books are stored in the elastic cloud where traffic is expensive. For this reason, we have a limit on daily download.